Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Autologous stem cell transplantation (ASCT) for acute myeloid leukemia in patients in first complete remission after one versus two induction courses: A study from the ALWP of the EBMT

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
  • معلومة اضافية
    • بيانات النشر:
      Wiley, 2023.
    • الموضوع:
      2023
    • Collection:
      LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
    • نبذة مختصرة :
      Abstract Background Achieving complete remission (CR) is the main goal in AML treatment and a prerequisite for successful autologous stem cell transplantation (ACT). Methods Comparing results of peripheral blood ACT in patients with AML in CR1 attained following 1 versus 2 chemotherapy courses transplanted in 2000–2019. Results Patients 1532 (84%) with one and 293 (16%) patients with two induction chemotherapies courses (a total of 1825 patients) were included in the study. Follow‐up was 7.9 (95% CI: 7.4–8.4) and 7.7 (95% CI: 7.0–8.6) years (p = 0.8). Time from diagnosis to ACT was 4.7 (range, 3.9–5.8) versus 5.7 (range, 4.7–7.1) months (p
    • File Description:
      electronic resource
    • ISSN:
      2045-7634
    • Relation:
      https://doaj.org/toc/2045-7634
    • الرقم المعرف:
      10.1002/cam4.5039
    • الرقم المعرف:
      edsdoj.4cd378cf9437447297a9c43b0459cddb